Star S4 Ir
Payments companies reported to CMS as associated with Star S4 Ir. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Star S4 Ir, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Star S4 Ir
These are the largest totals companies reported as associated with Star S4 Ir. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Joshua Young | New York, NY | Ophthalmology | $208,523.80 |
| Christopher Blanton | Colton, CA | Ophthalmology | $117,473.91 |
| Zaina Al-Mohtaseb | Houston, TX | Ophthalmology | $58,753.48 |
| Vance Thompson | Sioux Falls, SD | Ophthalmology | $32,832.17 |
| Marc Odrich | Charlottesville, VA | Ophthalmology | $25,963.58 |
| Rahul Tonk | Princeton, NJ | Ophthalmology | $17,184.30 |
| Edward Manche | Stanford, CA | Cornea and External Diseases Specialist | $13,740.51 |
| Deepinder Dhaliwal | Pittsburgh, PA | $8,793.79 | |
| Julio Albarracin | Dallas, TX | Ophthalmology | $4,375.00 |
| Ashraf Ahmad | Irvine, CA | Ophthalmology | $3,841.20 |
Prescribed Star S4 Ir?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.